<p>Changes in the prescribing of fluoroquinolone and second line injectable agents before and after 2013 in Tuberculosis Treatment Center, Yunnan Center of Disease Control, Yunnan, China.</p
WHO estimates that 9 million people developed active tuberculosis in 2013 and 1.5 million people die...
Background Understanding the impact of drug exposure and susceptibility on treatment response of mul...
China is transitioning towards concentrating tuberculosis (TB) diagnostic and treatment services in ...
China has a high burden of drug-resistant tuberculosis (TB). As irrational use and inadequate dosing...
<div><p>Objectives</p><p>China has a high burden of drug-resistant tuberculosis (TB). As irrational ...
<p>Flow chart on numbers of patients included in the anti-tuberculosis drug resistance surveillance ...
Objectives To examine changes in the screening, diagnosis, treatment and management of drug-resistan...
OBJECTIVE: To assess the availability of second-line drugs (SLDs) and the use of drug susceptibility...
Objectives To examine changes in the screening, diagnosis, treatment and management of drug-resistan...
Setting. Tuberculosis treatment requires long regimens with multiple antibiotics and is complicated ...
Background: Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (X...
Setting. Tuberculosis treatment requires long regimens with multiple antibiotics and is complicated ...
It was reported that 35.5% of tuberculosis (TB) cases reported in 2003 in Taipei City had no recorde...
Background/Aims This study was conducted to evaluate the recent prevalence and trend of anti-tubercu...
Background: Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (X...
WHO estimates that 9 million people developed active tuberculosis in 2013 and 1.5 million people die...
Background Understanding the impact of drug exposure and susceptibility on treatment response of mul...
China is transitioning towards concentrating tuberculosis (TB) diagnostic and treatment services in ...
China has a high burden of drug-resistant tuberculosis (TB). As irrational use and inadequate dosing...
<div><p>Objectives</p><p>China has a high burden of drug-resistant tuberculosis (TB). As irrational ...
<p>Flow chart on numbers of patients included in the anti-tuberculosis drug resistance surveillance ...
Objectives To examine changes in the screening, diagnosis, treatment and management of drug-resistan...
OBJECTIVE: To assess the availability of second-line drugs (SLDs) and the use of drug susceptibility...
Objectives To examine changes in the screening, diagnosis, treatment and management of drug-resistan...
Setting. Tuberculosis treatment requires long regimens with multiple antibiotics and is complicated ...
Background: Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (X...
Setting. Tuberculosis treatment requires long regimens with multiple antibiotics and is complicated ...
It was reported that 35.5% of tuberculosis (TB) cases reported in 2003 in Taipei City had no recorde...
Background/Aims This study was conducted to evaluate the recent prevalence and trend of anti-tubercu...
Background: Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (X...
WHO estimates that 9 million people developed active tuberculosis in 2013 and 1.5 million people die...
Background Understanding the impact of drug exposure and susceptibility on treatment response of mul...
China is transitioning towards concentrating tuberculosis (TB) diagnostic and treatment services in ...